Showing results (261-270 of 270) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 270 results.
The New England Journal of Medicine|June 5, 2024
Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon CancerMyriam Chalabi, Yara L Verschoor, Pedro Batista Tan, et al.
Nature|January 11, 2023
γδ T cells are effectors of immunotherapy in cancers with HLA class I defectsNatasja L de Vries, Joris van de Haar, Vivien Veninga, et al.
Nature Medicine|September 15, 2024
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trialPeter G M de Gooyer, Yara L Verschoor, Lauren D W van den Dungen, et al.
Nature Medicine|April 7, 2020
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancersMyriam Chalabi, Lorenzo F Fanchi, Krijn K Dijkstra, et al.
Research and Practice in Thrombosis and Haemostasis|April 10, 2025
The impact of pulmonary embolism on health outcomes of COVID-19 at 3 months after hospitalizationChantal Visser, Julia C Berentschot, Cindy M M de Jong, et al.
Nature Medicine|January 8, 2024
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trialYara L Verschoor, Joris van de Haar, José G van den Berg, et al.
Nature Protocols|December 13, 2023
Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practiceKris G Samsom, Linda J W Bosch, Luuk J Schipper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2023
International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait StrategyCarine El Sissy, Amos Kirilovsky, Christine Lagorce Pagès, et al.
Nature Medicine|September 16, 2024
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trialIris Nederlof, Olga I Isaeva, Manon de Graaf, et al.
The Lancet. Oncology|January 14, 2023
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort studyCédric Nesti, Konstantin Bräutigam, Marta Benavent, et al.
Pageof 27